Table 1.

Vaccine Schedule and Efficacies Modeled After Dagan et al. [17]

Age	PCV13 1 + 1	PCV13 2 + 1	PCV13 3 + 1	PCV7
at 2 mo	0.172	0.172	0.172	0.172
at 4 mo	0.172	0.270	0.270	0.270
at 6 mo	0.172	0.270	0.462	0.462
at 12 mo	0.172	0.501	0.501	0.501